This efficacy is dependent on CD4+ and CD8+ T cells while being NK-cell-independent, demonstrating the boost that these arming factors give to tumor-infiltrating T cells, allowing them to overcome the immunosuppressive tumor environment and clear tumors. This evidence concerns the gene CD8A and neoplasm.